Enjoy complimentary customisation on priority with our Enterprise License!
The emergency contraceptive pills market size is forecast to increase by USD 240.3 million, at a CAGR of 4.36% between 2023 and 2028. The growth of the market is influenced by several factors, including the rise in initiatives to create awareness about contraception methods and their importance. The increase in unplanned pregnancies is also driving the demand for contraceptives, as individuals seek effective methods to prevent unintended pregnancies. Additionally, the ease of online purchases has made contraceptives more accessible, further contributing to market growth. It also includes an in-depth analysis of market trends and analysis, market growth analysis and challenges. Furthermore, the report includes historic market data from 2018 - 2022.
To learn more about this report, View Report Sample
The market is influenced by organizations like the United Nations Populations Fund and advisory bodies such as the Advisory Committee on Immunization Practices (ACIP). Companies like Mayne Pharma offer ECP options like Drospirenone Tablets and Slynd Tablets to address demand surges. Reproductive health services play a crucial role, especially with abortion restrictions affecting access. The market includes OTC products like Plan B medication and pre-coital contraceptives such as Wisp, catering to sexually active women seeking emergency contraception. This market, including condoms and birth control options, serves a critical need for women worldwide, as highlighted by the Kaiser Family Foundation. Our researchers analyzed the market research and growth data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Market Driver
The rise in the number of initiatives to create awareness is notably driving the growth. Several governments and academic institutes are promoting the use of contraception, including emergency contraceptive pills. They are launching initiatives to aid individual users in acquiring cost-effective contraceptive solutions. For instance, NHS, through its service finder, allows a user to find a pharmacy or a clinic nearby to procure contraceptives. According to WHO, each year, 74 million women living in low and middle-income countries have an unintended pregnancy. The unplanned pregnancies are a result of a lack of information about contraception, sexual health, and a lack of open communication about sex.
Consequently, countries are taking initiatives aimed at reducing the rate of unplanned conceptions. These include advertising campaigns; sex education; access to and information about contraceptives; and discussion on sexual health with general practitioners, youth services, and specialized clinics. Thus, high awareness about contraception products such as emergency contraception pills is expected to fuel the market growth during the forecast period.
Major Market Trend
The importance of family planning is a key trend influencing the market growth. Unplanned pregnancies are a result of unprotected sexual intercourse, contraceptive failure, incorrect use of contraceptives, and sexual assault. The use of effective contraception can prevent abortion-related and pregnancy-related morbidity and mortality cases in developing countries. Many organizations promote voluntary family planning. Organizations such as the Asia Pacific Council on Contraception, the European Society of Cardiology.
Furthermore, the International Planned Parenthood Federation conduct programs to spread awareness about contraceptive drugs, such as emergency contraceptive pills. Government initiatives toward family planning and easy access to contraceptives have increased the popularity of contraceptive pills. Thus, an increase in awareness about the importance of family planning will support the growth of the market during the forecast period.
Signification Market Challenge
Local governments limiting access to emergency contraceptive pills may impede market growth. In 2013, the FDA approved the Plan B One-Step contraceptive pill, which can be acquired without prescription or age restrictions. However, the distribution of such products is restricted on moral or ethical grounds. For instance, states such as Massachusetts and the District of Columbia in the US require emergency rooms to dispense the drug on request to sexual assault victims.
However, other states such as Arizona, Arkansas, Georgia, Idaho, Mississippi, and South Dakota do not allow pharmacists to dispense contraceptives, including emergency contraception pills. The presence of such restrictions limits the adoption of emergency contraception pills in the US, which is an important market for companies. This leads to a loss of potential revenue for companies and hampers market growth.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
The research report also includes detailed analyses of the competitive landscape of the market and information about 18 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market share growth by the retail stores segment will be significant during the forecast period. Retail stores include supermarkets, hypermarkets, departmental stores, pharmacies and clinics, and other stores. The increase in disposable income and the availability of emergency contraceptive pills across different retail stores have made purchases convenient for consumers. In addition, the market has witnessed a rise in promotional offers by local pharmacy chains, which is leading to an increase in the sale of emergency contraceptive pills.
Get a glance at the market contribution of various segments View the PDF Sample
The retail stores segment showed a gradual increase in the market share of USD 562.50 million in 2018. Retail stores offer a range of options to consumers and have a strong presence in neighborhoods. The steady rise in the number of stores offering feminine contraceptive products is increasing the share of the retail stores segment in the global market.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. High product awareness and ease of availability in pharmacies, clinics, and online stores are driving the growth of the market in the region. Also, the increased incidences of unplanned pregnancies and widespread awareness regarding their ease of use have driven the market significantly. In addition, the region has a large number of companies, such as Afaxys, Foundation Consumer Healthcare, and Syzygy Healthcare, which allow effective distribution and timely availability of these products.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The Taiwan Centers for Disease Control reports a notable uptick in the demand for emergency contraceptive pills, particularly brands like Drovelis, Organon, Marvelon, and Mercilon. This surge is attributed to both increased instances of unprotected sex and stringent abortion bans in regions like the Southeast and Midwest. However, supply chain disruptions pose a challenge to pharmacy availability, impacting distribution channels such as hospital pharmacies. Despite this, the efficacy rate of both estrogen-progestin birth control pills and ulipristal acetate remains high, according to the National Library of Medicine. Key companies in the market, encompassing both branded and generic providers, vie for market share, a dynamic monitored by organizations like the American Chemical Society. With combined oral contraceptives and estrogen pills being primary options, ensuring accessibility and education on emergency contraception is imperative in contemporary healthcare systems.
Additionally, the morning-after pills market witnesses a significant demand surge amidst regional dynamics like abortion ban in the Southeast region and Midwest region. Understanding distribution channel insights becomes crucial, especially in navigating challenges posed by supply chain disruptions. Key companies & Market Share Insights strive for dominance, closely monitoring market share fluctuations. Meanwhile, scientific research delves into the role of calcium and sodium ions in contraceptive efficacy. As these factors shape the landscape, stakeholders must stay attuned to regional insights to effectively address emerging needs in emergency contraception.
Market Scope |
|
Report Coverage |
Details |
Page number |
162 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.36% |
Market Growth 2024-2028 |
USD 240.3 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.11 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 44% |
Key countries |
US, China, Germany, France, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
AbbVie Inc., Afaxys Pharma LLC, Bayer AG, Combe Inc., Foundation Consumer Healthcare LLC, Gedeon Richter Plc, HLL Lifecare Ltd., Knoll Healthcare Pvt. Ltd., Laboratoire HRA Pharma SAS, Lupin Ltd., Mankind Pharma Ltd., Morepen Laboratories Ltd., Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Ltd., Syzygy Healthcare LLC, and Teva Pharmaceutical Industries Ltd. |
Market dynamics |
Parent market analysis, Market forecast, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.